Literature DB >> 8301258

Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels.

G E Kirsch1, J A Drewe.   

Abstract

4-aminopyridine (4AP) is widely used as a selective blocker of voltage-activated K+ currents in excitable membranes, but its mechanism and site of action at the molecular level are not well understood. To address this problem we have analyzed 4AP block in Kv2.1 and Kv3.1, mammalian representatives of the Drosophila Shab and Shaw subfamilies of voltage-gated K+ channels, respectively. The two channels were expressed in Xenopus oocytes and analyzed at both the macroscopic and single channel levels. Whole cell analysis showed that 4AP sensitivity of Kv3.1 was approximately 150 times greater than that of Kv2.1. Patch clamp analysis revealed that the mechanism of 4AP block in both channels was qualitatively similar. 4AP reached its blocking site via the cytoplasmic side of the channels, the ON rate for block was strongly accelerated when channels opened and the drug was trapped in closed channels. Single channel analysis showed that 4AP decreased burst duration and increased the latency-to-first-opening. These effects were found to be related, respectively to drug ON and OFF rates in the activated channel. Kv3.1's high 4AP sensitivity relative to Kv2.1 was associated with both a slower OFF rate and therefore increased stability of the blocked state, as well as a faster ON rate and therefore increased access to the binding site. Our results indicate that in both channels 4AP enters the intracellular mouth to bind to a site that is guarded by the gating mechanism. Differences in channel gating as well as differences in the structure of the intracellular mouth may be important for specifying the 4AP sensitivity in related voltage-gated K+ channels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301258      PMCID: PMC2229176          DOI: 10.1085/jgp.102.5.797

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  53 in total

1.  Unmasking of a novel potassium current in Drosophila by a mutation and drugs.

Authors:  A Singh; S Singh
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  Properties and molecular basis of the mouse urinary bladder voltage-gated K+ current.

Authors:  Kevin S Thorneloe; Mark T Nelson
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

3.  Role of transmembrane segment S5 on gating of voltage-dependent K+ channels.

Authors:  C C Shieh; K G Klemic; G E Kirsch
Journal:  J Gen Physiol       Date:  1997-06       Impact factor: 4.086

4.  Ca2+ imaging of mouse neocortical interneurone dendrites: Ia-type K+ channels control action potential backpropagation.

Authors:  Jesse H Goldberg; Gabor Tamas; Rafael Yuste
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

5.  Targeting ion channels for the treatment of autoimmune neuroinflammation.

Authors:  Stefan Bittner; Sven G Meuth
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

6.  Fast delayed rectifier potassium current is required for circadian neural activity.

Authors:  Jason N Itri; Stephan Michel; Mariska J Vansteensel; Johanna H Meijer; Christopher S Colwell
Journal:  Nat Neurosci       Date:  2005-04-24       Impact factor: 24.884

7.  Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion.

Authors:  David A Jacobson; Andrey Kuznetsov; James P Lopez; Shera Kash; Carina E Ammälä; Louis H Philipson
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

8.  Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels.

Authors:  C C Shieh; G E Kirsch
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

9.  Block by 4-aminopyridine of a Kv1.2 delayed rectifier K+ current expressed in Xenopus oocytes.

Authors:  S N Russell; N G Publicover; P J Hart; A Carl; J R Hume; K M Sanders; B Horowitz
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

10.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.